Skip to main content

Table 1 Flow cytometric data of (A) apoptosis, (B) cell cycle and (C) ROS of T2, L3 treated cells and control MDA-MB-231 cells

From: Novel plasmon-coupled Ag/Ag2O nano-particles to downregulate β-catenin pathway in triple negative breast cancer

A

Sample

Tested conc. (μg/ml)

Early apoptosis

Last apoptosis

Necrosis

 
 

T2 (Treated cells)

0.93

1.94

27

15.32

 
 

L3 (Treated cells)

17.2

3.06

8.78

7.21

 
 

MDA-MB-231 cells (control)

0

0.49

0.15

1.2

 

B

Sample

Tested conc. (μg/ml)

% G0–G1

% S

% G2-M

% Pre G1

 

T2 (Treated cells)

0.93

55.03

41.92

3.05

44.26

 

L3 (Treated cells)

17.2

41.36

37.26

21.38

19.05

 

MDA-MB-231 cells (control)

0

46.04

41.26

12.7

1.84

C

Sample

Tested conc. (μg/ml)

∆RFU

% of control

  
 

T2 (Treated cells)

0.93

176,762.407

138.44

  
 

L3 (Treated cells)

17.2

164,754

129.02

  
 

MDA-MB-231 cells (control)

0

127,691.958

100